[1]
D. Sahin Eroglu, “Rituximab experience from a single centre for patients with rheumatoid arthritis-related interstitial lung disease: Rituximab in RA-ILD”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 39, no. 3, p. e2022029, Sep. 2022, doi: 10.36141/svdld.v39i3.12337.